PCM, Inc. to Present at Upcoming Investor Conferences

EL SEGUNDO, Calif.--(BUSINESS WIRE)-- PCM, Inc. (NASDAQ: PCMI), a leading technology solutions provider, announced today that its Chief Financial Officer, Brandon La Verne, is scheduled to present at three upcoming investor conferences:

• Sidoti & Company, LLC Emerging Growth Conference on Wednesday, September 2, at the New York Marriott Marquis in Times Square. PCM’s presentation will begin at 2:10 pm ET/11:10 am PT in the Music Box room.
• Rodman & Renshaw Annual Global Investment Conference on Wednesday, September 9, at the St. Regis Hotel in New York. PCM’s presentation will begin at 1:45 pm ET/10:45 am PT in the Fontainebleau Foyer.
• B. Riley & Co. and Great American Group Consumer Conference on Wednesday, September 16, at the New York Athletic Club. PCM’s presentation will begin at 3:35 pm ET/12:35 pm PT in the Olympic Suite 4.

The presentations will be webcast and will be available at the PCM investor relations website at investor.pcm.com, the webcasts and presentations will also be archived on the website for 90 days after each conference.

About PCM, Inc.

PCM, Inc., through its wholly-owned subsidiaries, is a leading technology solutions provider to small and medium sized businesses, mid-market and enterprise customers, government and educational institutions and individual consumers. Including pro forma results from our acquisition of En Pointe in April 2015, we generated over $1.7 billion in revenue in 2014. For more information please visit investor.pcm.com or call (310) 354-5600.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150827005931/en/

Genesis Select Corp.
Budd Zuckerman
303.415.0200
[email protected]

Source: PCM, Inc.

You May Also Be Interested In

• Hadrius Raises $27 Million to Build Agentic Compliance Infrastructure
• TerraFirma Raises $115M to Accelerate Construction on Earth and Beyond
• The DUST Test and Mosaic Diagnostics Announce Strategic Partnership to Advance Environmental and Clinical Correlation for Mold-Related Illness